These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17211054)

  • 1. The adverse effects of hallucinogens from intramural perspective.
    Frecska E; Luna LE
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):189-200. PubMed ID: 17211054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hallucinogen-induced psychological disorders].
    Hermle L; Kovar KA; Hewer W; Ruchsow M
    Fortschr Neurol Psychiatr; 2008 Jun; 76(6):334-42. PubMed ID: 18512184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelics and Personality.
    Aixalà M; Dos Santos RG; Hallak JEC; Bouso JC
    ACS Chem Neurosci; 2018 Oct; 9(10):2304-2306. PubMed ID: 29863323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
    Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory perspective on the evaluation of hallucinogen drugs for human use.
    Calderon SN; Hunt J; Klein M
    Neuropharmacology; 2018 Nov; 142():135-142. PubMed ID: 29180224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hallucinogens and Their Therapeutic Use: A Literature Review.
    Begola MJ; Schillerstrom JE
    J Psychiatr Pract; 2019 Sep; 25(5):334-346. PubMed ID: 31505518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological effects of ayahuasca in humans.
    dos Santos RG
    J Psychoactive Drugs; 2014; 46(5):383-8. PubMed ID: 25364989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.
    Reiche S; Hermle L; Gutwinski S; Jungaberle H; Gasser P; Majić T
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():1-10. PubMed ID: 28947181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.
    Dos Santos RG; Hallak JEC
    Neurosci Biobehav Rev; 2020 Jan; 108():423-434. PubMed ID: 31809772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of psilocybin.
    Passie T; Seifert J; Schneider U; Emrich HM
    Addict Biol; 2002 Oct; 7(4):357-64. PubMed ID: 14578010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.
    Schindler EA; Gottschalk CH; Weil MJ; Shapiro RE; Wright DA; Sewell RA
    J Psychoactive Drugs; 2015; 47(5):372-81. PubMed ID: 26595349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca].
    Szabó A; Kazai A; Frecska E; Brys Z
    Neuropsychopharmacol Hung; 2015 Sep; 17(3):120-8. PubMed ID: 26485742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of the hallucinogenic drugs.
    Seal RE
    Aust N Z J Psychiatry; 1970 Jun; 4(2):64-7. PubMed ID: 5286790
    [No Abstract]   [Full Text] [Related]  

  • 16. Hallucinogens and redemption.
    de Rios MD; Grob CS; Baker JR
    J Psychoactive Drugs; 2002; 34(3):239-48. PubMed ID: 12422934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinogens and dissociative agents naturally growing in the United States.
    Halpern JH
    Pharmacol Ther; 2004 May; 102(2):131-8. PubMed ID: 15163594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances.
    Abbott KL; Gill KS; Flannery PC; Boothe DM; Dhanasekaran M; Pondugula SR
    ACS Chem Neurosci; 2020 May; 11(10):1382-1384. PubMed ID: 32395981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.
    Bogenschutz MP
    Curr Drug Abuse Rev; 2013 Mar; 6(1):17-29. PubMed ID: 23627783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uses and abuses of L.S.D. and other hallucinogenic drugs.
    Barnes DT
    Aust N Z J Psychiatry; 1970 Dec; 4(4):170-3. PubMed ID: 5286778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.